Gustavo Büchele
Ionis Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Amyloidosis: Diagnosis, Treatment, Outcomes, Sepsis Diagnosis and Treatment, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Cardiac, Anesthesia and Surgical Outcomes, Respiratory Support and Mechanisms
Most-Cited Works
- → How to evaluate the microcirculation: report of a round table conference(2007)822 cited
- → The prognostic value of muscle StO2 in septic patients(2007)358 cited
- → Effects of fluids on microvascular perfusion in patients with severe sepsis(2010)322 cited
- → Multicenter, randomized, controlled trials evaluating mortality in intensive care: Doomed to fail?(2008)178 cited
- → Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy(2023)176 cited
- → Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction(2020)139 cited
- → Ligand Conjugated Antisense Oligonucleotide for the Treatment of Transthyretin Amyloidosis: Preclinical and Phase 1 Data(2020)86 cited
- → Effects of hydrocortisone on microcirculatory alterations in patients with septic shock*(2009)82 cited
- → Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy(2021)54 cited
- → Liver‐directed drugs for transthyretin‐mediated amyloidosis(2022)27 cited